2,075
Views
103
CrossRef citations to date
0
Altmetric
Review

Drug-induced crystal nephropathy: an update

, MD & , MD FACP
Pages 147-158 | Published online: 06 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

G. R. Tortella, J. C. Pieretti, O. Rubilar, M. Fernández-Baldo, A. Benavides-Mendoza, M. C. Diez & A. B. Seabra. (2022) Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives. Critical Reviews in Biotechnology 42:3, pages 431-449.
Read now
ZheLun Shen, QingQing Yu, YangLei Li, YiQi Bao & Hong Lu. (2020) Determination of acyclovir in renal microdialysis fluid and confirmation of renal function index. Drug and Chemical Toxicology 43:6, pages 574-580.
Read now
Mark A Perazella & Randy L Luciano. (2015) Review of select causes of drug-induced AKI. Expert Review of Clinical Pharmacology 8:4, pages 367-371.
Read now
Iva Hoffmanová, Pavel Kraml & Michal Anděl. (2015) Renal risk associated with sodium phosphate medication: safe in healthy individuals, potentially dangerous in others. Expert Opinion on Drug Safety 14:7, pages 1097-1110.
Read now
S Lochy, R Jacobs, PM Honoré, E De Waele, O Joannes-Boyau, J De Regt, V Van Gorp & HD Spapen. (2013) Phosphate induced crystal acute kidney injury – an under-recognized cause of acute kidney injury potentially leading to chronic kidney disease: case report and review of the literature. International Journal of Nephrology and Renovascular Disease 6, pages 61-64.
Read now
Armineh Zohrabian. (2010) Clinical and economic considerations of antiobesity treatment: a review of orlistat. ClinicoEconomics and Outcomes Research 2, pages 63-74.
Read now
Ronald Baynes & Jim Riviere. (2010) Risks associated with melamine and related triazine contamination of food. Emerging Health Threats Journal 3:1.
Read now

Articles from other publishers (96)

Isabelle Brocheriou, Kenar D. Jhaveri & Hassan Izzedine. (2023) How I Treat: An Algorithmic Approach to Crystalline Nephropathies. Clinical Journal of the American Society of Nephrology.
Crossref
Suryanarayana Polaka, Lakshmi Vineela Nalla, Rana Dhwani Kalpeshkumar, Paritala Sree Teja, Anand More, Muktika Tekade, Dinesh Kumar Chellappan & Rakesh Kumar Tekade. 2023. Essentials of Pharmatoxicology in Drug Research, Volume 1. Essentials of Pharmatoxicology in Drug Research, Volume 1 289 316 .
Radhika Sharma, Reshma Sinha, Ramneek Kaur & Seema Rani. 2023. Biomarkers in Toxicology. Biomarkers in Toxicology 797 829 .
Mark A. Perazella & Mitchell H. Rosner. (2022) Drug-Induced Acute Kidney Injury. Clinical Journal of the American Society of Nephrology 17:8, pages 1220-1233.
Crossref
Jessica E. Ericson, Daniel K. BenjaminJrJr, Felix Boakye-Agyeman, Stephen J. Balevic, C. Michael Cotten, Felice Adler-Shohet, Matthew Laughon, Brenda Poindexter, Barrie Harper, Elizabeth H. Payne, Kim Kaneshige & P. Brian Smith. (2022) Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease. Early Human Development 170, pages 105616.
Crossref
Faria Latif Sami, Hasan Hammo & Ambarish Athavale. (2022) Crystalline Nephropathy With High-Dose Methotrexate in a Patient With Primary CNS Lymphoma: A Case Report. Cureus.
Crossref
Carsten Willam, Melanie Meersch, Larissa Herbst, Peter Heering, Michael Schmitz, Michael Oppert, Stefan John, Achim Jörres, Alexander Zarbock, Uwe Janssens & Detlef Kindgen-Milles. (2021) Aktueller Stand der Durchführung von Nierenersatztherapien auf deutschen IntensivstationenPresent practise patterns of renal replacement therapy in German intensive care medicine. Medizinische Klinik - Intensivmedizin und Notfallmedizin 117:5, pages 367-373.
Crossref
Dennis G. MoledinaLeal C. Herlitz & Mark A. Perazella. (2022) Acute Interstitial Nephritis and Crystalline Nephropathies. Nephrology Self-Assessment Program 21:1, pages 50-70.
Crossref
Milo Gatti, Michele Fusaroli, Emanuel Raschi, Irene Capelli, Elisabetta Poluzzi & Fabrizio De Ponti. (2021) Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems. Journal of Nephrology 35:3, pages 1017-1027.
Crossref
Michael B. Stokes & Jacob S. Stevens. (2022) Vancomycin-Associated Cast Nephropathy: Reality or Fantasy?. Kidney360 3:2, pages 372-375.
Crossref
Winnie M. C. van den Boogaard, Daphne S. J. Komninos & Wilbert P. Vermeij. (2022) Chemotherapy Side-Effects: Not All DNA Damage Is Equal. Cancers 14:3, pages 627.
Crossref
Chaoling Chen, Dengpiao Xie, David A. Gewirtz & Ningjun Li. 2022. Strategies to Mitigate the Toxicity of Cancer Therapeutics. Strategies to Mitigate the Toxicity of Cancer Therapeutics 77 129 .
Radhika Sharma, Reshma Sinha, Ramneek Kaur & Seema Rani. 2022. Biomarkers in Toxicology. Biomarkers in Toxicology 1 33 .
Mark A. Perazella & Leal C. Herlitz. (2021) The Crystalline Nephropathies. Kidney International Reports 6:12, pages 2942-2957.
Crossref
Xuan Gao, Xiao-Wen Qian, Xiao-Hua Zhu, Yi Yu, Hui Miao, Jian-Hua Meng, Jun-Ye Jiang, Hong-Sheng Wang & Xiao-Wen Zhai. (2021) Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia. Frontiers in Pharmacology 12.
Crossref
Barbara Lenz, Andreas Brink, Michael J Mihatsch, Bernd Altmann, Urs Niederhauser, Bernd Steinhuber, Nicole Wyttenbach & Holger Fischer. (2021) Multiorgan Crystal Deposition of an Amphoteric Drug in Rats Due to Lysosomal Accumulation and Conversion to a Poorly Soluble Hydrochloride Salt. Toxicological Sciences 180:2, pages 383-394.
Crossref
O. V. Muslimova, V. A. Evteev & I. A. Mazerkina. (2020) Effect of Organic Anion Transporters on the Development of Nephrotoxicity in the Context of NSAIDs Use. Safety and Risk of Pharmacotherapy 8:4, pages 198-204.
Crossref
S. Lai, A. Sciarra, F. Pierella, S. Pastore, L. Piloni, S. Salciccia, A.M. Perrotta, P. Protopapa, G. Pintus, G. Ricciuti, M. Ciccariello & M. Von Heland. (2020) Chronic Kidney Disease and Urological Disorders: An Overview. Current Signal Transduction Therapy 15:2, pages 223-231.
Crossref
Miquel Martin, Ramon Boixeda, Axel Muñoz & Àngela Felip. (2020) Ciprofloxacin as a cause of acute renal failure. Enfermedades infecciosas y microbiologia clinica (English ed.) 38:8, pages 402-403.
Crossref
Miquel Martin, Ramon Boixeda, Axel Muñoz & Àngela Felip. (2020) Ciprofloxacino como causa de insuficiencia renal aguda. Enfermedades Infecciosas y Microbiología Clínica 38:8, pages 402-403.
Crossref
Anne-Sophie Garnier, Juliette Dellamaggiore, Benoit Brilland, Laurence Lagarce, Pierre Abgueguen, Alain Furber, Erick Legrand, Jean-François Subra, Guillaume Drablier & Jean-François Augusto. (2020) High Incidence of Amoxicillin-Induced Crystal Nephropathy in Patients Receiving High Dose of Intravenous Amoxicillin. Journal of Clinical Medicine 9:7, pages 2022.
Crossref
Zhenhong Li, John LitchfieldDavid A. TessAnthony A. Carlo, Heather Eng, Christopher Keefer & Tristan S. Maurer. (2020) A Physiologically Based in Silico Tool to Assess the Risk of Drug-Related Crystalluria . Journal of Medicinal Chemistry 63:12, pages 6489-6498.
Crossref
Danielle M. Kleppe, Akash D. Patel, Jonathan Goodin, Anthony B. Cardillo, Stephen Canon, Rebecca L. Latch, Mohammad Ilyas & Eric R. Rosenbaum. (2020) Amoxicillin-Induced Crystalline Nephropathy Presenting as Ureteral Obstruction. Clinical Pediatrics 59:6, pages 614-617.
Crossref
Nicolae Bacinschi, Lucia Ţurcan, Anastasia Caracaş, Tatiana Covalschi & Eugenia Vasilache. (2020) Nephrotoxicity induced by antimicrobial drugs. Farmacist.ro 4:195, pages 40.
Crossref
Daniel Marks, Andrew De La Paz & Bobbi Jo Walston. (2020) Acyclovir-induced neurotoxicity in an immunocompromised patient. SAGE Open Medical Case Reports 8, pages 2050313X2094651.
Crossref
Anthony Nicolaysen. (2020) Nephrotoxic Chemotherapy Agents: Old and New. Advances in Chronic Kidney Disease 27:1, pages 38-49.
Crossref
Wattana Leowattana. (2019) Antiviral Drugs and Acute Kidney Injury (AKI). Infectious Disorders - Drug Targets 19:4, pages 375-382.
Crossref
Reza Heidari. (2019) The footprints of mitochondrial impairment and cellular energy crisis in the pathogenesis of xenobiotics-induced nephrotoxicity, serum electrolytes imbalance, and Fanconi’s syndrome: A comprehensive review. Toxicology 423, pages 1-31.
Crossref
. 2019. Demystifying Drug Dosing in Renal Dysfunction. Demystifying Drug Dosing in Renal Dysfunction 101 151 .
Stefan Ruepp, Evan Janovitz, Thomas Brodie, Randy White, Joseph Santella, John Hynes, Julie Carman, Duohai Pan, Yang Wu, Umesh Hanumegowda, Brian Gemzik, John Megill, Janet DiPiero, Dieter Drexler, Ching-Chiang Su & Michael Hageman. (2019) Assessing the risk of drug crystallization in vivo. Journal of Pharmacological and Toxicological Methods 96, pages 1-8.
Crossref
Zhenhong Li, Ciaran Fisher, Iain Gardner, Avijit Ghosh, John Litchfield & Tristan S. Maurer. (2019) Modeling Exposure to Understand and Predict Kidney Injury. Seminars in Nephrology 39:2, pages 176-189.
Crossref
Erika J. Espinosa-Ortiz, Brian H. Eisner, Dirk Lange & Robin Gerlach. (2018) Current insights into the mechanisms and management of infection stones. Nature Reviews Urology 16:1, pages 35-53.
Crossref
Bryan M. Tucker & Mark A. Perazella. 2019. Nephrology Secrets. Nephrology Secrets 78 83 .
Fayez T. Hammad, Suhail Al-Salam, Priya Yuvaraju & Loay Lubbad. (2018) Alda-1, an aldehyde dehydrogenase-2 agonist, causes deterioration in renal functions following ischemia-reperfusion injury due to crystalline nephropathy. Drug Development Research 79:7, pages 315-323.
Crossref
Yufan Chao, Songyan Gao, Xuelei Wang, Na Li, Hongxia Zhao, Xiaofei Wen, Ziyang Lou & Xin Dong. (2018) Untargeted lipidomics based on UPLC-QTOF-MS/MS and structural characterization reveals dramatic compositional changes in serum and renal lipids in mice with glyoxylate-induced nephrolithiasis. Journal of Chromatography B 1095, pages 258-266.
Crossref
Aurélie Lavergne, Cécile Vigneau, Elisabeth Polard, Louise Triquet, Nathalie Rioux-Leclercq, Pierre Tattevin & Léonard Golbin. (2018) Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review. International Journal of Antimicrobial Agents 52:3, pages 344-349.
Crossref
Carolyn Vera Coulter. (2018) The role of the suspicious renal pharmacist in identifying unusual adverse drug reactions—why this is not a small problem. International Journal of Clinical Pharmacy 40:4, pages 775-777.
Crossref
C. John Sperati, Chi Zhang, Marco Delsante, Rajib Gupta, Serena Bagnasco & Ishan Barman. (2018) Raman Spectroscopy for the Diagnosis of Intratubular Triamterene Crystallization. Kidney International Reports 3:4, pages 997-1003.
Crossref
Barbara Lenz, Andreas Brink, Monira Siam, Anne De Paepe, Simon Bassett, Anne Eichinger-Chapelon, Pierre Maliver, Rachel Neff, Urs Niederhauser, Bernd Steinhuber, Raphael Zurbach, Thomas Singer, Christoph Funk, Franz Schuler, Mudher Albassam & Simone Schadt. (2018) Application of Imaging Techniques to Cases of Drug-Induced Crystal Nephropathy in Preclinical Studies. Toxicological Sciences 163:2, pages 409-419.
Crossref
Mark Ellul & Tom Solomon. (2018) Acute encephalitis – diagnosis and management. Clinical Medicine 18:2, pages 155-159.
Crossref
Nicolas Fabresse, Bénédicte Devictor, Christel Pissier, Hervé ChambostBruno Lacarelle, Gérard MichelCaroline Solas. (2018) Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate. Therapeutic Drug Monitoring 40:1, pages 76-83.
Crossref
Michel Daudon, Vincent Frochot, Dominique Bazin & Paul Jungers. (2017) Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment. Drugs 78:2, pages 163-201.
Crossref
Laura B. Ramsey, Frank M. Balis, Maureen M. O'Brien, Kjeld Schmiegelow, Jennifer L. Pauley, Archie Bleyer, Brigitte C. Widemann, David Askenazi, Sharon Bergeron, Anushree Shirali, Stefan Schwartz, Alexander A. Vinks & Jesper Heldrup. (2018) Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. The Oncologist 23:1, pages 52-61.
Crossref
John Curtis Seely, Gordon C. Hard & Brad Blankenship. 2018. Boorman's Pathology of the Rat. Boorman's Pathology of the Rat 125 166 .
Randy L. Luciano & Mark A. Perazella. 2018. Core Concepts in Acute Kidney Injury. Core Concepts in Acute Kidney Injury 145 163 .
Holly R Mabillard & Charles R V Tomson. (2017) Investigation and management of renal stone disease. Nephrology Dialysis Transplantation 32:12, pages 1984-1986.
Crossref
Dominick Santoriello, Majdi Al-Nabulsi, Aravinda Reddy, Julius Salamera, Vivette D. D’Agati & Glen S. Markowitz. (2017) Atazanavir-Associated Crystalline Nephropathy. American Journal of Kidney Diseases 70:4, pages 576-580.
Crossref
Hassan Izzedine & Mark A. Perazella. (2017) Anticancer Drug-Induced Acute Kidney Injury. Kidney International Reports 2:4, pages 504-514.
Crossref
S. Teege, T. Wiech & O. M. Steinmetz. (2017) Akutes Nierenversagen bei einer 75-jährigen Patientin mit High-output-IleostomaAcute renal failure in a 75-year-old woman with a high-output ileostoma. Der Internist 58:5, pages 507-511.
Crossref
Kjeld Schmiegelow & Inge van der Sluis. 2017. Childhood Acute Lymphoblastic Leukemia. Childhood Acute Lymphoblastic Leukemia 99 138 .
Risa Matsubara, Tetsuya Kibe & Takemasa Nomura. (2016) Crystalline nephropathy caused by tosufloxacin. Pediatrics International 58:11, pages 1219-1221.
Crossref
Laura N. Poloni, Anthony P. Ford & Michael D. Ward. (2016) Site Discrimination and Anisotropic Growth Inhibition by Molecular Imposters on Highly Dissymmetric Crystal Surfaces. Crystal Growth & Design 16:9, pages 5525-5541.
Crossref
Phylicia Baird, Sam Leung, Huy Hoang, Olawumi Babalola, Craig E Devoe, Rimda Wanchoo & Kenar D Jhaveri. (2015) A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use. Journal of Oncology Pharmacy Practice 22:2, pages 357-360.
Crossref
Xinlin Wu, Jianxiang Liu, Jianqing Zhang, Heng Liu, Miansheng Yan, Birong Liang, Hongbo Xie, Shijun Zhang, Baoguo Sun & Houming Zhou. (2016) Folic acid reverses uric acid crystal-induced surface OAT1 internalization by inhibiting RhoA activity in uric acid nephropathy. Molecular Medicine Reports.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 555 569 .
Mark A. Perazella. (2015) The Urine Sediment as a Biomarker of Kidney Disease. American Journal of Kidney Diseases 66:5, pages 748-755.
Crossref
Sahar M. El-Gowilly, Mai M. Helmy & Hanan M. El-Gowelli. (2015) Pioglitazone ameliorates methotrexate-induced renal endothelial dysfunction via amending detrimental changes in some antioxidant parameters, systemic cytokines and Fas production. Vascular Pharmacology 74, pages 139-150.
Crossref
Assunta Bianco, Giovanni Gambaro, Paolo Maria Rossini & Massimiliano Mirabella. (2015) Acyclovir-related kidney injury during alemtuzumab infusion. Journal of Neurology 262:7, pages 1772-1774.
Crossref
Yueming Liu, Qiang He & Mao Wu. (2015) Levofloxacin-induced crystal nephropathy. Nephrology 20:6, pages 437-438.
Crossref
Josef Edrik Keith Bautista, Basma Merhi, Oliver Gregory, Susie Hu, Kammi Henriksen & Reginald Gohh. (2015) Heroin crystal nephropathy. Clinical Kidney Journal 8:3, pages 339-342.
Crossref
M. Reid Groseclose, Susan B. Laffan, Kendall S. Frazier, Angela Hughes-Earle & Stephen Castellino. (2015) Imaging MS in Toxicology: An Investigation of Juvenile Rat Nephrotoxicity Associated with Dabrafenib Administration. Journal of the American Society for Mass Spectrometry 26:6, pages 887-898.
Crossref
Varun Agrawal, Pamela C. Gibson, Amrik Sahota & Samih H. Nasr. (2015) Quiz Page May 2015. American Journal of Kidney Diseases 65:5, pages A17-A19.
Crossref
R. L. Luciano & M. A. Perazella. (2014) Crystalline-induced kidney disease: a case for urine microscopy. Clinical Kidney Journal 8:2, pages 131-136.
Crossref
Ali J. Olyaei & Edgar V. Lerma. 2015. Dermatological Manifestations of Kidney Disease. Dermatological Manifestations of Kidney Disease 221 253 .
Norbert Laube, Wolfgang Berg, Falk Bernsmann, Sascha Gravius, Florian Klein, Stefan Latz, Dirk von Mallek, Tadeusz Porowski, Thomas Randau, Anna Wasilewska & Christian Fisang. (2014) Induced urinary crystal formation as an analytical strategy for the prediction and monitoring of urolithiasis and other metabolism-related disorders. EPMA Journal 5:1.
Crossref
Katalin Csordas, Orsolya Lautner-Csorba, Agnes F. Semsei, Andrea Harnos, Marta Hegyi, Daniel J. Erdelyi, Oliver T. Eipel, Csaba Szalai & Gabor T. Kovacs. (2014) Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia . British Journal of Haematology 166:3, pages 410-420.
Crossref
S. R. Mulay, A. Evan & H.-J. Anders. (2013) Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrology Dialysis Transplantation 29:3, pages 507-514.
Crossref
Dominique Bazin, Jean-Philippe Haymann, Emmanuel Letavernier, Julie Rode & Michel Daudon. (2014) Calcifications pathologiques : un diagnostic médical basé sur leurs paramètres physicochimiques. La Presse Médicale 43:2, pages 135-148.
Crossref
Ya-Li Hsiao, Pei-Chun Chang, Hung-Jin Huang, Chia-Chen Kuo & Calvin Yu-Chian Chen. (2014) Treatment of Acute Lymphoblastic Leukemia from Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-21.
Crossref
Mia von Euler, Gudmundur Axelsson & Anders Helldén. (2013) Differential Diagnosis of Central Nervous System Involvement in a Patient Treated With Acyclovir. Therapeutic Drug Monitoring 35:4, pages 417-419.
Crossref
Maria Moeller Rasmussen, Regitse Hoejgaard Christensen, Jannie Gregers, Jesper Heldrup, Jacob Nersting & Kjeld Schmiegelow. (2013) Can SLC19A1 80G>A Polymorphisms Predict Risk of Extremely Delayed MTX excretion After High Dose of Methotrexate?. Journal of Pediatric Hematology/Oncology 35:5, pages 417-418.
Crossref
Ngan N. Lam, Matthew A. Weir, Zhan Yao, Peter G. Blake, Michael M. Beyea, Tara Gomes, Sonja Gandhi, Muhammad Mamdani, Ron Wald, Chirag R. Parikh, Daniel G. Hackam & Amit X. Garg. (2013) Risk of Acute Kidney Injury From Oral Acyclovir: A Population-Based Study. American Journal of Kidney Diseases 61:5, pages 723-729.
Crossref
Pritam Sahota, James Popp, Jerry Hardisty & Chirukandath GopinathKendall Frazier & John Seely. 2013. Toxicologic Pathology. Toxicologic Pathology 421 484 .
Johan Bylund, Anita Annas, Dennis Hellgren, Sivert Bjurström, Håkan Andersson & Alexander Svanhagen. (2013) Amide Hydrolysis of a Novel Chemical Series of Microsomal Prostaglandin E Synthase-1 Inhibitors Induces Kidney Toxicity in the Rat. Drug Metabolism and Disposition 41:3, pages 634-641.
Crossref
Katalin Csordas, Marta Hegyi, Oliver T. Eipel, Judit Muller, Daniel J. Erdelyi & Gabor T. Kovacs. (2013) Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia. Anti-Cancer Drugs 24:2, pages 189-197.
Crossref
A. Jarfaut, R. Santucci, D. Levêque & R. Herbrecht. (2013) Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin. Médecine et Maladies Infectieuses 43:1, pages 39-41.
Crossref
J Salazar, A Altés, E del Río, J Estella, S Rives, M Tasso, A Navajas, J Molina, M Villa, J L Vivanco, M Torrent, M Baiget & I Badell. (2011) Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia. The Pharmacogenomics Journal 12:5, pages 379-385.
Crossref
Leal C. Herlitz, Vivette D. D'Agati & Glen S. Markowitz. (2012) Crystalline Nephropathies. Archives of Pathology & Laboratory Medicine 136:7, pages 713-720.
Crossref
Kendall S. Frazier, John Curtis Seely, Gordon C. Hard, Graham Betton, Roger Burnett, Shunji Nakatsuji, Akiyoshi Nishikawa, Beate Durchfeld-Meyer & Axel Bube. (2012) Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System. Toxicologic Pathology 40:4_suppl, pages 14S-86S.
Crossref
Lynn Thomas & Jennifer OthersenPranay Kathuria & Anand Khurana. 2012. Nutrition Therapy for Chronic Kidney Disease. Nutrition Therapy for Chronic Kidney Disease 55 72 .
Mark A. Perazella. 2012. Nephrology Secrets. Nephrology Secrets 78 84 .
Peter Greaves. 2012. Histopathology of Preclinical Toxicity Studies. Histopathology of Preclinical Toxicity Studies 537 614 .
Katalin Csordás, Olivér Eipel, Márta Hegyi, Monika Csóka, Éva Pap & Gábor Kovács. (2011) Pharmacokinetic analysis of high-dose methotrexate treatments in children with hematologic malignancies. Orvosi Hetilap 152:40, pages 1609-1617.
Crossref
Rolando Claure-Del Granado, Etienne Macedo & Ravindra L. Mehta. (2011) Urine Microscopy in Acute Kidney Injury: Time for a Change. American Journal of Kidney Diseases 57:5, pages 657-660.
Crossref
Isaac Teitelbaum & Scott Liebman. 2011. Textbook of Critical Care. Textbook of Critical Care 902 908 .
R. Reimschuessel, E.R. Evans, C.B. Stine, N. Hasbrouck, T.D. Mayer, C. Nochetto & C.M. Gieseker. (2010) Renal crystal formation after combined or sequential oral administration of melamine and cyanuric acid. Food and Chemical Toxicology 48:10, pages 2898-2906.
Crossref
Yohannes Hagos & Natascha A. Wolff. (2010) Assessment of the Role of Renal Organic Anion Transporters in Drug-Induced Nephrotoxicity. Toxins 2:8, pages 2055-2082.
Crossref
Richard L Thompson & Nancy M Sawtell. (2010) Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency. Future Medicinal Chemistry 2:7, pages 1099-1105.
Crossref
Manuel Dominguez-Estevez, Anne Constable, Paolo Mazzatorta, Andrew G. Renwick & Benoit Schilter. (2010) Using urinary solubility data to estimate the level of safety concern of low levels of melamine (MEL) and cyanuric acid (CYA) present simultaneously in infant formulas. Regulatory Toxicology and Pharmacology 57:2-3, pages 247-255.
Crossref
S. H. Nasr, S. Sethi, L. D. Cornell, D. S. Milliner, M. Boelkins, J. Broviac & M. E. Fidler. (2010) Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrology Dialysis Transplantation 25:6, pages 1909-1915.
Crossref
Ravi Parasuraman & K.K. Venkat. (2010) Crystal-Induced Kidney Disease in 2 Kidney Transplant Recipients. American Journal of Kidney Diseases 55:1, pages 192-197.
Crossref
Natascia Corti, Alexander Imhof & Christa Wenger. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 461 489 .
Eric V. Granowitz & Richard B. Brown. 2009. Infectious Diseases in Critical Care Medicine. Infectious Diseases in Critical Care Medicine 542 556 .
Kjeld Schmiegelow. (2009) Advances in individual prediction of methotrexate toxicity: a review. British Journal of Haematology 146:5, pages 489-503.
Crossref
B. A. Vervaet, A. Verhulst, P. C. D'Haese & M. E. De Broe. (2009) Nephrocalcinosis: new insights into mechanisms and consequences. Nephrology Dialysis Transplantation 24:7, pages 2030-2035.
Crossref
Christoph Boesecke & David A Cooper. (2008) Toxicity of HIV protease inhibitors: clinical considerations. Current Opinion in HIV and AIDS 3:6, pages 653-659.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.